WallStreetZenWallStreetZen

NASDAQ: SNY
Sanofi Earnings & Revenue

SNY past earnings growth

How has SNY's earnings growth performed historically?
Company
-32.73%
Industry
19.7%
Market
127.73%
SNY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SNY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SNY's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SNY past revenue growth

How has SNY's revenue growth performed historically?
Company
6.87%
Industry
9.32%
Market
19.15%
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNY earnings and revenue history

Current Revenue
$51.6B
Current Earnings
$6.0B
Current Profit Margin
11.6%
SNY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SNY Return on Equity

Current Company
7.3%
Current Industry
34.1%
Current Market
188%
SNY's Return on Equity (7.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SNY announces earnings.

SNY Return on Assets

Current Company
4.3%
Current Industry
8.3%
SNY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNY Return on Capital Employed

Current Company
8.13%
Current Industry
14.8%
SNY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNY vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNY$49.94B$14.09B$5.81B+4.70%+3.84%
GILD$27.45B$4.81B$484.00M+4.22%-38.59%
PFE$55.09B$4.69B-$309.00M+6.07%N/A
BMY$45.53B$4.00B-$6.15B+14.35%N/A
GSK$37.95B$7.29B$5.54B-1.11%+1.40%

SNY earnings dates

Next earnings date
Jul 25, 2024

Sanofi Earnings & Revenue FAQ

What were SNY's earnings last quarter?

On Invalid Date, Sanofi (NASDAQ: SNY) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Sanofi earnings for the quarter were N/A. In the same quarter last year, Sanofi's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Sanofi stock.

What was SNY's earnings growth in the past year?

As of Q3 2024, Sanofi's earnings has grown -32.73% year over year. This is 52.43 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19.7%. Sanofi's earnings in the past year totalled $5.81 billion.

What is SNY's earnings date?

Sanofi's earnings date is Invalid Date. Add SNY to your watchlist to be reminded of SNY's next earnings announcement.

What was SNY's revenue last quarter?

On Invalid Date, Sanofi (NASDAQ: SNY) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Sanofi's revenue was N/A.

What was SNY's revenue growth in the past year?

As of Q3 2024, Sanofi's revenue has grown 6.87% year over year. This is 2.45 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 9.32%. Sanofi's revenue in the past year totalled $49.94 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.